Célia Regina Gonçalves e Silva

Célia Regina Gonçalves e Silva

Auto-generated profile, based on publicly available information

Célia Regina Gonçalves e Silva

Universidade de Taubaté, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
MLMariella Vieira Pereira Leão
Mariella Vieira Pereira Leão
TTTalita Angelina Aureliano Tavares
Talita Angelina Aureliano Tavares
CSCélia Regina Gonçalves e Silva
Célia Regina Gonçalves e Silva
SSSilvana Soleo Ferreira dos Santos
Silvana Soleo Ferreira dos Santos
Juliana JunqueiraJuliana Junqueira
Juliana Junqueira
AJAntonio Olavo Cardoso Jorge
Antonio Olavo Cardoso Jorge

1 June 2018 in RGO - Revista Gaúcha de Odontologia
Verified
Journal Article
Open access
PDF file
MPMaitê Alves Pequeno
Maitê Alves Pequeno
MSMarissa Rodrigues Silvestre
Marissa Rodrigues Silvestre
IAIsabela Amêndola
Isabela Amêndola
CSCélia Regina Gonçalves e Silva
Célia Regina Gonçalves e Silva
MLMariella Vieira Pereira Leão
Mariella Vieira Pereira Leão
SSSilvana Soleo Ferreira dos Santos
Silvana Soleo Ferreira dos Santos
Objective: This research study aimed at evaluating the inhibitory activity of Matricaria recutira (chamomile) hydroalcoholic extract on Candida albicans and Enterobacter cloacae biofilms. Methods: C. albicans and E. cloacae biofilms with thirty-hour formation were submitted, for five minutes, to 100, 200 and 300 mg / mL of M. recutita hydroalcoholic extract, chlorhexidine digluconate 0.12% (Periogard® - inhibition control) or sterile distilled water (growth control). Subsequently, they were washed and divided into two groups to determine the microbial viability: G/UFC - counting of colony forming units (cfu) in agar and G/DNA - quantification of viable DNA with violet crystal dye by spectrophotometry. Results: M. recutita extract at 300 mg/mL reduced significantly (p <0.01) the E. cloacae cfu/mL number in biofilm with results similar to chlorhexidine 0.12%, while extracts at 100 and 200 mg/mL did not have the same effectiveness. The amount of E. cloacae viable DNA was reduced (p <0.05) in all the M. recutita extract concentrations and chlorhexidine. There was no significant difference (p = 0.565) in the cfu/mL number or in the amount of viable DNA (p = 0.8094) in C. albicans biofilm when compared to untreated biofilm (control) or, even, between the extracts when compared to each other or to chlorhexidine 0.12%. Conclusion: 300 mg/mL M. recutita extract reduced significantly the E. cloacae biofilm but not the C. albicans, both with a similar result to chlorhexidine 0.12% (Periogar®).